Mariavittoria D'acierno
Ariano Irpino-martiri, 83031, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI.
Journal: Science translational medicine
Published: November 01, 2023
Bardet-Biedl syndrome: The pleiotropic role of the chaperonin-like BBS6, 10, and 12 proteins.
Journal: American journal of medical genetics. Part C, Seminars in medical genetics
Published: November 14, 2021
The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb.
Journal: Molecular genetics and metabolism reports
Published: October 12, 2021
Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 13, 2021
Label-free quantitative proteomics of the MCF-7 cellular response to a ferritin-metallodrug complex.
Label-free quantitative proteomics of the MCF-7 cellular response to a ferritin-metallodrug complex.
Journal: Molecular omics
Published: February 05, 2020
Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 07, 2020
ERK1,2 Signalling Pathway along the Nephron and Its Role in Acid-base and Electrolytes Balance.
Journal: International journal of molecular sciences
Published: July 19, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026